Global Perfusion Imaging Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.
Perfusion imaging market is a product and technology advancement driven market. The advancements in technology such as positron tomography which allows for qualitative real data about the organ under study. The latest development involve development of shorter life time radioactive materials thus reducing the radioactive exposure of the patient.
The rise of ageing population coupled with the rising cases of cardiac problems is the most important factor driving the market. Collaboration between large players and hospitals helps to reduce the costs and results in lower maintenance costs. It also results in greater market penetration and reduced marketing times and costs.
Perfusion imaging involves passage of fluid through the blood vessels of an organ and scanning, the flow of perfusion quality and quantity deviations from the normal using a number of medical imaging modalities. Radioactive material called tracers are mixed with blood and are injected into the organ to be studies using photographs by a special gamma camera which reveals qualitative and quantitative changes based on the supply of blood.
Single photon emission computed tomography is the latest technological advancement for perfusion imaging and is being seen as an alternative to positron emission tomography (PET).
Considering all these factors the market for perfusion imaging is expected to reach $ 12.03 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 8.2 % during 2017-2023.
Key players for Global Perfusion Imaging market:
- Apollo Medical Imaging Technology Pty. Ltd.
- Cigna, kmhlabs, Novadaq Technologies Inc.
- GE Healthcare
- Siemens Health
- Philips Healthcare
- Toshiba Medical Systems
- NeuSoft
- Bracco, and Lantheus Medical Cardiac Imaging Solutions Inc.
- Perimed AB.
- Positron
- Aetna Inc. and others.
Segments:
The global perfusion imaging market is segmented on the basis of methods. Based on the methods, the market has been segmented as microspheres, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine and other. Based on the applications, the market has been segmented as ventilation perfusion imaging, myocardial perfusion imaging, functional brain imaging, testicular torsion detection and other.
Regional Analysis
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/perfusion-radiology-market-8419
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment